Post procedure clopidogrel cuts amputation rates

Clopidogrel use after endovascular lower-extremity revascularization was significantly associated with 1-year freedom from amputation and survival, but only 38 percent of the Medicare population was on the drug post intervention in a large retrospective analysis. Patients with the most severe peripheral vascular disease, ulceration, or gangrene benefited the most from post revascularization clopidogrel (Plavix), but were the least likely to be using the drug, Dr

Read the article:
Post procedure clopidogrel cuts amputation rates

Previous post:

Next post: